Journal of Experimental & Clinical Cancer Research (Sep 2023)

Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma

  • Fei Teng,
  • Ju-Xiang Zhang,
  • Qi-Meng Chang,
  • Xu-Bo Wu,
  • Wei-Guo Tang,
  • Jian-Fa Wang,
  • Jin-Feng Feng,
  • Zi-Ping Zhang,
  • Zhi-Qiu Hu

DOI
https://doi.org/10.1186/s13046-023-02824-9
Journal volume & issue
Vol. 42, no. 1
pp. 1 – 1

Abstract

Read online

No abstracts available.